Certuma launches Argentina operations with US$10M seed round led by 8VC
Certuma, a clinical artificial intelligence startup founded in December 2025 by Argentine-Spanish serial entrepreneur Martín Varsavsky, has initiated operations in Argentina following a US$10 million seed financing round led by 8VC, the Austin-based venture capital firm cofounded by Joe Lonsdale, who also cofounded data analytics company Palantir with Peter Thiel.
Varsavsky brings over three decades of serial entrepreneurship, having founded more than ten companies including telecommunications firms Jazztel and Viatel, autonomous mobility venture Goggo Network, and reproductive health companies Prelude Fertility, Overture Life, and Gameto. Gameto has secured FDA Investigational New Drug approval and is currently in Phase 3 trials. Bruno Marino, appointed Head of LATAM for Certuma, is directing regional growth from Argentina.
The seed capital will fund two parallel regulatory tracks: FDA approval in the United States and homologation by Argentina's ANMAT, the national regulatory authority for medical products. Certuma is scaling its clinical platform and infrastructure to serve healthcare institutions across Latin America.
Certuma's core technology is MedCanon, a proprietary clinical reasoning engine powering Certuma Copilot, an AI assistant that records and organizes information during medical consultations, assists with clinical reasoning, and automates administrative tasks. In Argentina, where diagnosis and prescription remain exclusive legal prerogatives of licensed physicians, Certuma operates strictly as an assistant without making clinical decisions.
Before you start hiring
Check location, salary, and hiring fit
If you are moving from research to action, start with the market basics so your hiring plan is clearer.
"We are not seeking to replace the physician," Marino stated. "The final decision and signature remain with the professional. We believe the value of AI lies in expanding physicians' capacity and returning time to them for cases where their experience is indispensable."
A precedent exists in the United States. The Permanente Medical Group, part of Kaiser Permanente, documents more than 2.5 million annual uses of similar tools and savings exceeding 15,700 hours of medical documentation.
How clinical AI expansion signals urgent healthcare workforce demand across LATAM
Certuma's Argentina launch responds to structural workforce pressures across the region. The Pan American Health Organization projects Latin America will face a deficit of between 600,000 and 2 million health workers by 2030. In Argentina, the concentration of medical centers in Buenos Aires and rising vacancies in medical residency programs deepen this challenge.
Clinical AI tools positioned as physician assistants represent one approach to extending operational capacity of existing healthcare teams. For employers building healthtech teams in Argentina, this dynamic creates dual talent demand: clinical professionals who can work effectively with AI-augmented workflows and engineers, regulatory specialists, and commercial roles required to scale these platforms.
The global market for AI-powered clinical documentation grew from US$1.23 billion in 2025 and is forecast to reach US$12.78 billion by 2035, a compound annual growth rate of 26 percent. This expansion is driving investment in regional infrastructure, regulatory expertise, and localized product development.
Companies entering Latin America's healthtech sector must navigate fragmented regulatory environments, varying data privacy frameworks, and diverse healthcare delivery models. Certuma's dual-track regulatory strategy illustrates this complexity. Organizations hiring AI talent for healthcare expansion in LATAM need professionals who understand both technical requirements of clinical AI and regulatory landscapes of target markets.
As AI tools reduce time spent on documentation and administrative tasks, healthcare organizations may reallocate clinical staff toward higher-complexity cases or patient-facing activities. This shift can influence compensation structures, training requirements, and workforce planning across the sector.
Hiring trends to monitor as Certuma scales regulatory approvals and regional infrastructure
Certuma's expansion creates immediate demand for regulatory affairs specialists familiar with FDA pathways and ANMAT requirements for software as a medical device. Managing parallel approvals in two jurisdictions requires professionals who can oversee clinical validation studies, compile technical documentation, and navigate post-market surveillance obligations.
As the platform scales across Latin America, Certuma will need commercial teams with knowledge of regional healthcare procurement, implementation specialists to integrate AI tools into clinical workflows, and customer success professionals who can train medical staff and demonstrate productivity gains.
Technical infrastructure supporting clinical AI demands specialized talent: natural language processing engineers capable of handling medical terminology in Spanish, data scientists who can validate clinical reasoning algorithms against regional patient populations, and cloud infrastructure specialists who can ensure compliance with health data residency and privacy requirements.
For employers across healthtech, Certuma's market entry signals intensifying competition for professionals with combined expertise in AI, healthcare, and Latin American regulatory frameworks. Organizations planning regional expansion should anticipate longer recruitment cycles for senior regulatory and clinical validation roles.
Compensation benchmarks for AI and healthtech roles in Argentina remain below US levels but are rising as venture capital flows into the market. Employers offering equity participation, opportunities to work on FDA-track products, and exposure to clinical AI may gain advantages in attracting senior technical and regulatory talent.
Healthcare professionals who develop fluency in AI-assisted clinical workflows position themselves for roles in product development, clinical validation, and medical affairs at technology companies. Medical institutions investing in staff training for AI-integrated workflows may improve retention and operational efficiency as these capabilities become standard expectations across the sector.